Top Markets
#1 Islamic Coin Islamic Coin +155.77%
#2 Siren Siren +36.63%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.27%
#4 Arowana Arowana +18.13%
#5 Cysic Cysic +17.36%
#6 aPriori aPriori +15.54%
#7 PulseChain PulseChain +14.70%
#8 Perle Perle +14.18%
#9 The Grays Currency The Grays Currency +13.97%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.23%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Kedudukan dalam Saham #31528
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Harga Saham
$1.02
Modal Pasaran
$12.96M
Perubahan (1 hari)
-0.92%
Perubahan (1 tahun)
-43.11%
Negara
FR
Perdagangan NFL Biosciences S.A. (ALNFL)

Kategori

Healthcare
Pendapatan untuk NFL Biosciences S.A. (ALNFL)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini NFL Biosciences S.A., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi NFL Biosciences S.A. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR